MODI — personalized insulin dosing with a CGM

Bringing automated insulin optimization to 85% of insulin users who rely on injections.

MODI is the first FDA-cleared app to bring dosing automation to people with type 2 diabetes who rely on injections, including those using both long-acting insulin alone or multiple daily injections (MDI).

MODI translates a patient’s CGM patterns and insulin data into clear insulin dosing recommendations.
Recommendations are delivered directly to the user through a mobile application.

Let's Connect

Patients onboard themselves. Providers just prescribe.

Patients enter their weight and their long-acting and short-acting insulin plans on their own time. There is no setup visit to get started, and the HCP only needs to write the prescription.

On the patient's schedule. Onboarding happens at home, whenever it suits them.
No provider setup. HCPs prescribe, and that is the extent of getting a patient started.
Ongoing data-driven guidance. No HCP approval required to approve each therapy recommendation.